Catabasis Pharmaceuticals - Articles and news items

Catabasis Pharmaceuticals announces preliminary Phase 1 data for hypercholesterolaemia product candidate CAT-2054

Industry news / 4 June 2015 / Victoria White

Catabasis has announced preliminary Phase 1 clinical trial data for CAT-2054 – its candidate for the potential treatment of hypercholesterolaemia…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+